ArticleScientific reports2026
Exploring the relative contribution of genetic and external exposomic risk scores to allergies in elderly women.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Allergies have been linked to immune dysfunction, genetics, and environmental factors. However, environmental exposures are often highly correlated similar to genetic predictors making the cumulative assessment of exposures difficult. Here, we aim to investigate the relative contribution of genetic variants as well as different individual and environmental factors on the presence or absence of allergies in 450 elderly German women enrolled in the SALIA cohort study living in the Ruhr area by using genetic risk score (GRS) and exposomal risk scores (ERS). We used the novel cross leverage scores (CLS) to select genetic variants to be included in the GRS. The weights of the risk scores were obtained through bootstrapped and cross-validated ridge regression. We characterized the relative contributions of the risk scores to presence of allergies such as atopic dermatitis, asthma, or allergic rhinitis using McFadden's Pseudo R-squared. Overall, our model was able to explain 11.13% of the variance of allergy diagnosis. The modest variance explained is consistent with prior work on complex polygenic and environmentally influenced traits, reflecting that no single exposure or domain is likely to fully capture individual risk. The GRS had the highest relative contribution at 3.80%, followed by the meteorological risk score with 1.13%. This method can easily be adapted to other diseases and can facilitate health risk assessments of exposomal factors. In addition, the results may aid policy-making, for example, by regulating specific sources of exposure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.